News & Headlines: Allergy Education and Management

FDA Approves First Drug For Treatment Of Peanut Allergy For Children

Tuesday, February 4, 2020  
Share |

The U.S. Food and Drug Administration approved Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] to mitigate allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts. Treatment with Palforzia may be initiated in individuals ages 4 through 17 years with a confirmed diagnosis of peanut allergy and may be continued in individuals 4 years of age and older. Those who take Palforzia must continue to avoid peanuts in their diets. 


The PTNPA is "The Voice of America's Nut Industry"